Citius Pharmaceuticals Inc

NASDAQ:CTXR   3:59:58 PM EDT
1.56
+0.03 (+1.96%)
4:55:36 PM EDT: $1.55 -0.01 (-0.64%)
Earnings Announcements

Citius Pharmaceuticals Reports Fiscal Full Year 2021 Financial Results

Published: 12/15/2021 22:40 GMT
Citius Pharmaceuticals Inc (CTXR) - Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2021 Financial Results and Provides Business Update.
Citius Pharmaceuticals Inc - $70.1 Million in Cash and Cash Equivalents As of September 30, 2021 to Advance Pipeline.
Citius Pharmaceuticals Inc - Estimate That We Will Have Sufficient Funds for Our Operations Through March 2023.
Citius Pharmaceuticals Inc - Net Loss per Share $0.23 for the Full Year Ended Sep 30.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.03

Next Quarter Revenue Guidance is expected to be $19.16 Million
Next Quarter EPS Guidance is expected to be $0.07

More details on our Analysts Page.